Profil
Sarah Mathieson, formerly the Chief Executive Officer of The Research Autism Information Service, Vice President-Corporate Communications at Adamas Pharmaceuticals LLC, Global Head-Communications & Engagement at GSK Plc, and Head-Communications at Pfizer Ltd., also served as the Senior Vice President-Corporate Affairs at Eiger BioPharmaceuticals, Inc. from 2022 to 2023.
Ehemalige bekannte Positionen von Sarah Mathieson
| Unternehmen | Position | Ende |
|---|---|---|
| EIGER BIOPHARMACEUTICALS | Corporate Officer/Principal | 01.03.2023 |
| ADAMAS PHARMACEUTICALS, INC. | Public Communications Contact | 24.11.2021 |
Pfizer Ltd.
Pfizer Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures medicines, vaccines & pharmaceutical products | Public Communications Contact | - |
| GSK PLC | Public Communications Contact | - |
The Research Autism Information Service
The Research Autism Information Service Miscellaneous Commercial ServicesCommercial Services Provides autism information services | Vorstandsvorsitzender | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
Adamas Pharmaceuticals LLC
Adamas Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets therapeutics for neurological diseases | Health Technology |
GSK Plc
GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
Pfizer Ltd.
Pfizer Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures medicines, vaccines & pharmaceutical products | Health Technology |
The Research Autism Information Service
The Research Autism Information Service Miscellaneous Commercial ServicesCommercial Services Provides autism information services | Commercial Services |
Eiger BioPharmaceuticals, Inc.
Eiger BioPharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies to treat and cure hepatitis delta virus and other serious diseases | Health Technology |
















